Literature DB >> 6160893

Cutaneous T cell lymphoma: characterization by monoclonal antibodies.

P C Kung, C L Berger, G Goldstein, P LoGerfo, R L Edelson.   

Abstract

Monoclonal antibodies to human T cells permit the characterization of the surface phenotype of cutaneous T cell lymphoma (CTCL). The majority of CTCL cells are reactive with OKT1 and OKT3 monoclonals, which identify peripheral T cells and mature thymocytes. The neoplastic cells also react with OKT4, which recognizes the inducer T cell subset; they are, however, unreactive with OKT5 monoclonal, which identifies cytotoxic/suppressor T cell subsets. These data are in agreement with previous functional studies demonstrating that CTCL is a neoplasm of inducer (helper) T cells.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6160893

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  25 in total

1.  Outsmarting cutaneous T-cell lymphoma cells by decoding the language they speak: focusing past and present insights on future prospects.

Authors:  Richard L Edelson
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2010-09

2.  Tonsillar mapping of determinants found on normal lymphoreticular (T,B,K, immature and macrophage) and myeloblastic leukemia cells.

Authors:  E M McMillan; L Stoneking; G B Humphrey; J Rapacz
Journal:  Am J Pathol       Date:  1987-03       Impact factor: 4.307

3.  Immunohistochemical study of epidermal Langerhans cells and dermal dendritic cells in benign and malignant skin lesions characterized by a dermal lymphoid infiltrate consisting either of B-cells or T-cells.

Authors:  M Drijkoningen; C De Wolf-Peeters; J Snauwaert; H De Greef; V Desmet
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1987

4.  Immunophenotypic differences between dermatopathic lymphadenopathy and lymph node involvement in mycosis fungoides.

Authors:  L M Weiss; G S Wood; R A Warnke
Journal:  Am J Pathol       Date:  1985-08       Impact factor: 4.307

5.  Reactivity of monoclonal antibody BE 2 in different stages of mycosis fungoides and in benign dermal infiltrates.

Authors:  P Kaudewitz; R Soldner; G Burg; T Bieber; C Berger; R Edelson; P Rieber; O Braun-Falco
Journal:  Arch Dermatol Res       Date:  1986       Impact factor: 3.017

6.  Advantages of fixed stored materials for immunoelectron microscopy, with special reference to the study of malignant lymphomas.

Authors:  H Akatsuka; K Kito; M Shamoto; T Suchi
Journal:  J Clin Pathol       Date:  1984-08       Impact factor: 3.411

7.  Immunohistochemical studies using monoclonal antibodies on lymph nodes from patients with mycosis fungoides and Sézary's syndrome.

Authors:  R Willemze; E Scheffer; C J Meijer
Journal:  Am J Pathol       Date:  1985-07       Impact factor: 4.307

8.  Routine flow cytometric diagnosis of lymphoproliferative disorders.

Authors:  I G Barr; B H Toh
Journal:  J Clin Immunol       Date:  1983-04       Impact factor: 8.317

9.  Human T-cell malignancies: Correlative clinical, histopathologic, immunologic, and cytochemical analysis of 23 cases.

Authors:  D M Knowles; J P Halper
Journal:  Am J Pathol       Date:  1982-02       Impact factor: 4.307

10.  Interleukin-7 is a growth factor for Sézary lymphoma cells.

Authors:  A Dalloul; L Laroche; M Bagot; M D Mossalayi; C Fourcade; D J Thacker; D E Hogge; H Merle-Béral; P Debré; C Schmitt
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.